clindamycin (Novalar)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameclindamycin (Novalar)
Drug Alias Nameclindamycin (Forsyth Institute)clindamycinNV-201
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBacterial proteins synthesis inhibitors
TargetsBacterial proteins
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesThe Forsyth Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A